Your browser is no longer supported. Please, upgrade your browser.
Settings
CORV Correvio Pharma Corp. daily Stock Chart
CORV [NASD]
Correvio Pharma Corp.
Index- P/E- EPS (ttm)-0.90 Insider Own0.80% Shs Outstand51.51M Perf Week-5.50%
Market Cap19.72M Forward P/E- EPS next Y-0.42 Insider Trans0.00% Shs Float49.35M Perf Month-8.20%
Income-36.70M PEG- EPS next Q-0.12 Inst Own76.60% Short Float0.85% Perf Quarter-78.49%
Sales30.30M P/S0.65 EPS this Y29.50% Inst Trans-0.14% Short Ratio0.14 Perf Half Y-80.37%
Book/sh0.03 P/B12.76 EPS next Y46.80% ROA-60.90% Target Price3.12 Perf Year-82.44%
Cash/sh0.35 P/C1.11 EPS next 5Y28.00% ROE- 52W Range0.35 - 4.44 Perf YTD-6.63%
Dividend- P/FCF- EPS past 5Y-26.80% ROI-16.30% 52W High-91.38% Beta0.35
Dividend %- Quick Ratio1.30 Sales past 5Y44.80% Gross Margin70.80% 52W Low9.68% ATR0.09
Employees173 Current Ratio1.50 Sales Q/Q-4.30% Oper. Margin-90.20% RSI (14)25.49 Volatility4.06% 9.90%
OptionableYes Debt/Eq29.33 EPS Q/Q-13.30% Profit Margin- Rel Volume0.87 Prev Close0.38
ShortableYes LT Debt/Eq22.07 EarningsFeb 13 BMO Payout- Avg Volume3.01M Price0.38
Recom2.80 SMA20-5.96% SMA50-70.94% SMA200-80.82% Volume2,695,139 Change0.60%
Dec-11-19Downgrade H.C. Wainwright Buy → Neutral
Sep-03-19Initiated Cantor Fitzgerald Overweight $6
Dec-04-18Initiated B. Riley FBR Buy $7
Oct-12-18Upgrade Mackie Research Hold → Buy
Jan-16-20 01:42PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline CORV GlobeNewswire
10:20AM  Correvio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm Newsfile
Jan-15-20 04:32PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baozun, Adamas Pharmaceuticals, Cintas, and Correvio Pharma and Encourages Investors to Contact the Firm GlobeNewswire
Jan-14-20 08:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE
10:22AM  Correvio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm Newsfile
Jan-13-20 04:44PM  CORV DEADLINE: Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Correvio Pharma Corp. CORV GlobeNewswire
02:10PM  INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jan-10-20 11:00AM  DEADLINE ALERT for ACB, PRU, FCAU, CORV: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:09AM  INVESTOR ALERT: CTAS and CORV: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders With Losses Exceeding $100K of Class Action Deadlines ACCESSWIRE
Jan-09-20 03:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Adamas Pharmaceuticals, Cintas, Correvio Pharma, and Exelon and Encourages Investors to Contact the Firm GlobeNewswire
09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline CORV GlobeNewswire
01:05AM  LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm PR Newswire
Jan-08-20 06:00PM  ROSEN, A LEADING LAW FIRM, Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Class Action CORV GlobeNewswire
Jan-06-20 04:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE
03:38PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Correvio Pharma Corp. CORV GlobeNewswire
Jan-03-20 04:30PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline CORV GlobeNewswire
11:30AM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation Business Wire
Jan-02-20 06:00PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:30PM  Zhang Investor Law Announces Securities Class Action Lawsuit Against Correvio Pharma Corp. CORV GlobeNewswire
12:00PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cintas, Correvio Pharma, Exelon, and Green Dot, and Encourages Investors to Contact the Firm GlobeNewswire
12:00PM  Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Correvio Pharma Corporation Business Wire
Dec-31-19 02:40PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE
Dec-29-19 09:40PM  Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus Benzinga
Dec-28-19 02:16PM  ROSEN, NATIONAL TRIAL LAWYERS, Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action CORV GlobeNewswire
Dec-27-19 02:00PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE -9.62%
Dec-26-19 08:20PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE +18.99%
Dec-24-19 04:04PM  SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline CORV GlobeNewswire +8.98%
02:55PM  IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM  TOP RANKED ROSEN LAW FIRM Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action CORV Business Wire
08:50AM  FDA Gives Thumbs Down To Correvio's Atrial Fibrillation Drug Benzinga
08:11AM  Microcap Correvio Pharma stock slammed after FDA rejects anti-arrhythmic drug MarketWatch
08:00AM  Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events CNW Group
Dec-23-19 04:00PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Correvio Pharma Corporation Investors Business Wire +14.57%
12:00PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Correvio Pharma Corporation Investors Business Wire
Dec-22-19 12:08PM  The Week Ahead In Biotech: Correvio, Intra-Cellular Therapies Await FDA Decisions Benzinga
Dec-21-19 09:10AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE
Dec-20-19 04:55PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:00AM  INVESTOR ALERT - Correvio Pharma Corp. (CORV) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020 GlobeNewswire
Dec-19-19 10:20PM  Hedge Funds Have Never Been More Bullish On Correvio Pharma Corp. (CORV) Insider Monkey
04:50PM  SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
04:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV ACCESSWIRE
02:30PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Correvio Pharma Corporation Investors Business Wire
11:30AM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Correvio Pharma Corporation Investors Business Wire
Dec-18-19 07:30PM  CORV LOSS NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Correvio Pharma Corp.; Encourages Investors with Losses in Excess of $100K to Contact the Firm CORV GlobeNewswire
Dec-17-19 04:37PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline CORV GlobeNewswire -7.72%
02:37PM  Correvio Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm Newsfile
Dec-16-19 05:36PM  Shareholder Alert: Robbins LLP Announces Correvio Pharma Corp. (CORV) Sued for Misleading Shareholders Business Wire +5.57%
04:40PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:41AM  INVESTOR ALERT - Correvio Pharma Corp. (CORV) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020 ACCESSWIRE
Dec-15-19 03:49PM  The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week Benzinga
11:30AM  CORV LOSS NOTICE: TOP RANKED Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Correvio Pharma Corp. - CORV PR Newswire
Dec-13-19 04:15PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
08:10AM  The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer Benzinga
Dec-12-19 07:15PM  CORREVIO PHARMA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Correvio Pharma Corp. and Encourages Investors to Contact the Firm Business Wire -15.22%
04:42PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
03:47PM  EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Correvio Pharma Corp. CORV Business Wire
07:38AM  The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win Benzinga
Dec-11-19 08:53AM  UPDATE 1-Correvio Pharma to explore sale after FDA panel setback, shares plunge Reuters -67.14%
08:25AM  Correvio Pharma to consider a sale after FDA adcomm vote MarketWatch
08:21AM  Correvio Pharma to explore sale after FDA panel setback; shares hit record low Reuters
08:16AM  Correvio Pharma to explore sale after FDA panel setback Reuters
08:00AM  Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value CNW Group
07:21AM  The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga
Dec-10-19 04:38PM  Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess For The Treatment Of Recent Onset Atrial Fibrillation PR Newswire
03:19PM  UPDATE 2-Correvio suffers fresh blow as heart drug fails to win FDA panel backing Reuters
02:23PM  Correvio's heart drug fails to win FDA panel backing Reuters
11:54AM  Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 10, 2019: NFLX, AZO, CORV, FRAN, LITB Benzinga
10:49AM  Correvio Pharma In The Spotlight Amid Brinavess Adcom Verdict Benzinga
08:40AM  Correvio stock halted ahead of FDA adcomm MarketWatch
07:05AM  Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess For Recent Onset Atrial Fibrillation PR Newswire
Dec-09-19 03:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Correvio Pharma Corporation - CORV ACCESSWIRE +7.69%
Dec-06-19 06:01PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Correvio Pharma Corporation  CORV GlobeNewswire -39.81%
08:54AM  UPDATE 2-Correvio slumps after FDA staffers say benefits of heart drug do not outweigh risks Reuters
08:28AM  Correvio slips after FDA staffers say benefits of heart drug do not outweigh risks Reuters
Dec-03-19 07:16AM  If You Had Bought Correvio Pharma (TSE:CORV) Stock Five Years Ago, You'd Be Sitting On A 72% Loss, Today Simply Wall St.
Nov-25-19 08:00AM  Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference CNW Group
Nov-18-19 08:00AM  Correvio Announces Presentation of New Brinavess Spectrum Data at the American Heart Association 2019 Annual Meeting PR Newswire
Nov-14-19 07:00AM  Correvio Reports Third Quarter 2019 Financial Results PR Newswire
Nov-07-19 08:00AM  Correvio to Report Third Quarter 2019 Financial Results CNW Group -7.22%
Nov-04-19 07:00AM  Correvio Announces FDA Advisory Committee Meeting to Review Brinavess for Recent Onset Atrial Fibrillation CNW Group +12.37%
Sep-30-19 10:42AM  Correvio Pharma Corp. (TSE:CORV) Is Expected To Breakeven Simply Wall St.
Sep-27-19 07:00AM  Correvio to Present at the 2019 Cantor Global Healthcare Conference PR Newswire -10.71%
07:00AM  Correvio to Present at the 2019 Cantor Global Healthcare Conference CNW Group
Sep-12-19 07:00AM  Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application CNW Group
Sep-04-19 08:00AM  Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference PR Newswire
08:00AM  Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference CNW Group
Sep-03-19 08:00AM  Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress PR Newswire
08:00AM  Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress CNW Group
Aug-16-19 02:45PM  Is Correvio Pharma (TSE:CORV) Using Too Much Debt? Simply Wall St.
Aug-14-19 07:00AM  Correvio Reports Second Quarter 2019 Financial Results PR Newswire
07:00AM  Correvio Reports Second Quarter 2019 Financial Results CNW Group
Aug-12-19 08:00AM  Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress PR Newswire +6.83%
Aug-08-19 08:00AM  Correvio to Report Second Quarter 2019 Financial Results CNW Group
Aug-07-19 09:20AM  Correvio Closes Public Offering of 9,200,000 Common Shares PR Newswire
09:20AM  Correvio Closes Public Offering of 9,200,000 Common Shares CNW Group
Aug-02-19 09:10AM  Correvio Announces Pricing Of Public Offering Of Common Shares PR Newswire -15.14%
09:10AM  Correvio Announces Pricing Of Public Offering Of Common Shares CNW Group
Aug-01-19 04:24PM  Correvio Announces Overnight Marketed Offering of Common Shares PR Newswire
04:24PM  Correvio Announces Overnight Marketed Offering of Common Shares CNW Group
Jul-25-19 07:00AM  U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant) PR Newswire
Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide. Its portfolio of marketed brands comprise Aggrastat (tirofiban hydrochloride) for patients with acute coronary syndrome; and Brinavess (vernakalant IV) for the rapid conversion of recent onset atrial fibrillation to sinus rhythm. The company also offers ESMOCARD and ESMOCARD LYO, a short acting beta blocker for the treatment of supraventricular tachycardia and control of the ventricular rate in patients with atrial fibrillation; Trevyent, a development stage drug/device combination product for pulmonary arterial hypertension; Xydalba, a treatment for acute bacterial skin and skin structure infections; and Zevtera/Mabelio, a cephalosporin antibiotic for intravenous administration with rapid bactericidal activity. Correvio Pharma Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.